期刊文献+

华法林相关维生素K环氧化物还原酶复合体亚单位1及细胞色素P450 2C9基因型快速检测的方法研究 被引量:2

The efficient method for detecting vitamin K epoxide reductase complex subunit 1 and cytochrome P450 2C9 after the treatment of warfarin.
在线阅读 下载PDF
导出
摘要 目的建立一种快速、准确、简便、经济的检测维生素K环氧化物还原酶复合体亚单位1(VKORC1)和细胞色素P450 2C9(CYP2C9)基因型的方法。方法提取220例肺栓塞患者外周血的DNA,针对2个基因的SNP位点设计特异性引物,并进行荧光聚合酶链反应(PCR),根据荧光PCR的熔解曲线分析样本的基因型。同时对样本进行传统的限制性酶切片段长度多态性(PCR—RFLP)基因分型,从时间、通量、费用、准确性等方面对2种方法进行比较。结果VKORC1 1693G〉A和CYP2C91 075A〉C两个SNP位点的不同基因型具有不同的熔解曲线峰型。220例样本中,VKORC1基因AA型184例,AG型34例,GG型2例,各占83.6%、15.5%、0.9%;CYP2C9基因*1/*1型加1例,*1/*3型19例,各占91.4,%、8.6%,无*3/*3型纯合子。PCR-RFLP检测结果与上述结果基本相同。2种方法相比,前者较后者操作步骤少,用时少,费用相当,结果更准确。结论利用荧光PCR检测VKORC1及CYP2C9的SNP分型操作简便、快速、经济、准确,适用于临床实验室开展基因分型。 Objective To establish a rapid, accurate, simple and economical method for detecting gene polymorphisms of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP2C9). Methods The DNA extracted from the peripheral blood from 220 patients with pulmonary embolism were examined. The specific primers were designed regarding of the two gene SNP sites, and the real tiem PCR was performed. According to the fluorescence PCR melting curve, sample genotypes were analyzed. At the same time, the genotypes of these samples were detected by the traditional restriction enzyme fragment length polymorphism ( PCR - RFLP). The expense of the time, the cost and the accuracy of two methods were compared. Results Different genotypes of VKORCl-1693 G 〉 A and CYP2C9 1075 A 〉 C has different melt curve peak patterns. Among 220 samples, there were 177 cases VKORC1 AA of 34 cases, AG 2cases GG, which represente 83.6%, 15.5%, 0. 9% respectively; CYP2C9 * 1/* 1 201 cases, 19 cases * 1/* 3 type, each accounted for 91.4 % , 8.6%, no * 3/* 3 homozygote. The testing results of PCR - RFLP were basically the same with the former. Comparing the two kinds of methods, the PCR method need less operation steps, spent less time, cost equal, and the results are more accurate than the latter. Conclusion Fluorescence PCR is the fast, simple, economic and accurate method to detect the genotypes of VKORC1 and CYP2C9 which is suitable for the genotyping in clinical laboratory.
出处 《中国医药》 2013年第4期472-474,共3页 China Medicine
基金 北京市科技计划课题(Z101107050210044)
关键词 荧光聚合酶链反应 维生素K环氧化物还原酶 细胞色素P450 2C9 Fluorescence polymerase chain reaction Vitamin K epoxide reductase complex subunt 1 Cytochrome P450 2C9
  • 相关文献

参考文献7

  • 1Takahashi H, Echizen H. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin. Pharmacogenomics J, 2003,3 (4) :202-214.
  • 2Yuan HY, Chen JJ, Lee MT, et al. A novel functional VKORCI promoter polymorphism is associated with inter-individual and interethnic differences in warfarin sensitivity. Hum Mol Genet, 2005,14 ( 13 ) : 1745-1751.
  • 3Wang J, Chuang K, Ahluwalia M, et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques, 2005,39 (6) : 885-893.
  • 4高秀丽,景奉香,杨剑波,赵建龙.单核苷酸多态性检测分析技术[J].遗传,2005,27(1):110-122. 被引量:31
  • 5Zhu J, Zhang W, Li Y, et al. ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese. Pharmacogenomics, 2010,11 ( 1 ) : 113-119.
  • 6都丽萍,梅丹,刘昌伟,刘暴,苏薇.CYP2C9及VKORC1基因多态性对华法林剂量和抗凝效果的影响[J].中国药学杂志,2010,45(21):1628-1633. 被引量:38
  • 7Wang TL, Li HL,Tjang WY, et al. Genetic factors contribute to patient-specific warfarin dose for Han Chinese. Clin Chim Acta, 2008,396(1-2) :76-79.

二级参考文献55

  • 1Sosnowski R G, Tu E, Butler W F, O'Connell J P, Heller M J. Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control.Proc Natl Acad Sci, 1997,94:1119~1123.
  • 2Patrick N Gilles, David J Wu, Charles B Foster, Patrick J Dillon, Stephen J Chanock. Single nucleotide polymorphic discrimination by an electric dot blot assay on semiconductor microchips.Nature Biotechnology, 1999,17:365~370.
  • 3Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen A C. A system for specific,high-throughput genotyping by allele-specific primer extension on microarrays.Genome Res,2000, 10:1031~1042.
  • 4Bray M S, Boerwinkle E, Doris P A. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise.Hum Muta, 2001,17:296~304.
  • 5Sascha Sauer, David H Gelfand, Francis Boussicault, Keith Bauer, Fred Reichert, Ivo G Gut. Facile method for automated genotyping of single nucleotide polymorphisms by mass spectrometry.Nucleic Acids Res, 2002,30:5e22.
  • 6Wang D G, Fan J B, Siao C J, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, Hsie L, Topaloglou T, Hubbell E, Robinson E, Mittmann M, Morris M S, Shen N, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson T J, Lander E S. Large-scale identification, mapping,and genotyping of single-nucleotide polymorphisms in human genome.Science,1998, 280:1077~1082.
  • 7Brookes A J. The essence of SNPs.Gene,1999, 234:177~186.
  • 8Tyagi S, Bratu D P,Kramer F R. Multiclor molecular beacons for allele discrimination.Nat Biotechnol,1998,16:49~53.
  • 9Janet A,Nila A,Xiyin Chen. New Developments in high-throughput resequencing and variation detection using high density microarrays.Human Mutation,2002,19:402~409.
  • 10Wallace R B, J Shaffer, R F Murphy, J Bonner,T Hirose,K Itakura. Hybridization of synthetic oligodeoxyribonucleotides to phiX174 DNA:The effect of single base pair mismatch.Nucl Acids Res,1979, 6:3543~3557.

共引文献67

同被引文献22

  • 1何震宇,孙丽敏,李月琴,潘伟,杨红.广东人群CYP2C9等位基因及基因型分布频率[J].广东医学,2006,27(8):1131-1132. 被引量:13
  • 2王宗社,舒端朝,魏涛,王小军,王淑霞.机械瓣置换术后华法林抗凝治疗的临床研究[J].中国心血管病研究,2007,5(2):124-126. 被引量:13
  • 3Westaway K, Cruickshank M, Roberts G W, et al. Fac- tors influencing over-anticoagulation and bleeding in war- farin therapy during the initial five months of treatment [J]. Aust Nurs J, 2010,17(10) :28-31.
  • 4Levine M N, Raskob G, Beyth R J, et al. Hemorrhagic complications of anticoagulant treatment : the Seventh AC- CP Conference on Antithrombotic and Thrombolytic Ther- apy[ J]. Chest, 2004,126(3 Suppl) : S287-S310.
  • 5Hirsh J, Fuster V, Ansell J, et al. American Heart As- sociation/American College of Cardiology Foundation guide to warfarin therapy [ J ]. Circulation, 2003, 107 (12) :1692-1711.
  • 6Fihn S D, McDonetl M, Martin D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study[J]. Ann Intern Med, 1993,118(7) :511-520.
  • 7Levine M N, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment [ J]. Chest,2001,119(1 Suppl) :S108-S121.
  • 8Beyth R J, Quinn L, Landefeld C S. A multieomponent intervention to prevent major bleeding complications in ol- der patients receiving warfarin: A randomized, controlled trial [ J ]. Ann Intern Med, 2000,133 ( 9 ) : 687-695.
  • 9McMahan D A, Smith D M, Carey M A, et al. Risk of major hemorrhage for outpatients treated with warfarin [J]. J Gen Intern Med, 1998,13(5):311-316.
  • 10Kirchheiner J, Brockmoller J. Clinical consequences of cytochrome P450 2C9 polymorphisms[ J ]. Clin Pharmacol Ther, 2005,77( 1 ) : 1-16.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部